查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871029

按递送类型、技术、应用和最终用户分類的酶促DNA合成市场—2025-2032年全球预测

Enzymatic DNA Synthesis Market by Offering, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，酵素 DNA 合成市场将成长至 12.1377 亿美元，复合年增长率为 20.74%。

关键市场统计数据
基准年 2024 2.6858亿美元
预计年份：2025年 3.1956亿美元
预测年份 2032 12.1377亿美元
复合年增长率 (%) 20.74%

对酶促DNA合成技术的引入、其科学基础、工业应用以及相关人员为何应立即参与进行策略概述

酶促DNA合成代表了核苷酸序列构建方式的重大变革，它摒弃了传统的化学亚磷酰胺法，转而采用酶方法，有望提高DNA的长度、保真度并减少对环境的影响。本文将读者置于分子生物学、酶学和工业流程设计的交叉领域，阐述了核心生化机制（模板依赖型连接酶和聚合酵素系统，以及模板非依赖型末端转移酶策略），并重点介绍了酶工程、流程自动化和整合品管如何融合，从而开启新的可能性。

酶驱动平台、自动化和计算设计如何改变合成范式，从而实现永续、可扩展和精确的DNA製造

随着酵素合成方法从实验室概念验证发展成为实用化的平台，DNA合成领域正经历一场变革性的转变。传统上，化学合成占据主导地位，但酵素工程的进步、製程控制的改进以及与自动化和生物资讯学的融合，重塑了DNA合成的价值模式。这些进步消除了危险试剂的使用，并实现了更温和的反应条件，从而降低了製程复杂性，并为合成更长、更精确的寡核苷酸和构建体铺平了道路。

对 2025 年美国关税如何重塑供应链、采购方式以及全球取得关键合成原料的途径进行分析性回顾。

2025年美国关税政策的实施，为支持酵素DNA合成的全球供应链增添了新的复杂性，影响了筹资策略、供应商选择和成本结构。对关键物料（例如特种酵素、高纯度试剂和资本设备）采购计画的直接营运影响最为显着，跨境物流和关税可能导致交货时间的波动和延误。这促使采购团队重新评估其供应商组合，优先考虑关键零件的库存缓衝，并加快更靠近最终组装地点的替代供应商的资格认证。

对产品、技术、应用和最终用户进行详细的細項分析，以发现驱动因素、限制因素和高价值机会。

对市场区隔的深入理解揭示了不同维度——产品、技术、应用和最终用户——如何驱动不同的需求和投资重点。按产品划分，市场分为「产品」和「服务」。产品包括耗材和试剂盒、DNA合成仪器和平台以及酵素和试剂；服务包括客製化DNA和寡核苷酸合成、基因和DNA文库合成、诱变和克隆服务以及次世代定序和DNA分析服务。每个细分市场都有不同的创新和收入动态：耗材需要稳定的供应和一致的质量，平台需要资金和生命週期支持，而服务则受吞吐量、品质保证和客户回应时间的驱动。

影响投资决策、合作模式和应用的区域趋势（美洲、欧洲、中东和非洲、亚太地区）

区域趋势将在塑造酶促DNA合成技术在全球市场的应用、商业化和监管方式方面发挥关键作用。在美洲，活跃的创投活动、成熟的生物技术丛集以及下游治疗药物研发的巨大需求，为该平台的早期应用创造了有利环境。同时，监管路径和报销环境也鼓励设备供应商和服务实验室之间的合作。相较之下，欧洲、中东和非洲地区（EMEA）的管理体制、研究资金筹措模式以及公私合营模式各不相同，这些因素影响着该技术的应用速度。在该地区，合规性、跨境合作和永续性标准日益受到重视。

酶促DNA合成领域创新、平台部署和策略联盟的主要企业的竞争格局和伙伴关係策略

对主要企业的分析表明，酶促DNA合成领域的竞争优势取决于技术差异化、策略伙伴关係和智慧财产权的综合作用。主要企业通常将专有的酵素设计技术、平台整合技术以及持续的耗材供应模式结合，从而建立稳定的收入来源。最成功的企业往往也会与学术机构和合约实验室进行策略合作，检验新型化学技术并加速其在实际应用中的推广。

为产业领导者提供实用指导，以加速酵素DNA合成技术的应用，降低供应链风险，并协调研发和商业策略。

希望利用酶促DNA合成技术的产业领导者应采取技术、营运和商业性相结合的措施，以加快价值实现速度并降低执行风险。首先，应优先投资于酵素优化和製程分析，以提高合成保真度和循环效率。在生产流程中展现可重复的性能将有助于建立客户信心并促进技术应用。同时，应开发模组化平台架构和可互通的软体，以实现增量升级、与实验室资讯管理系统整合以及顺畅的客户检验流程。

透明的调查方法，详细说明了资料来源、检验方法、专家访谈和分析方法，从而得出严谨的研究结果。

本分析的调查方法强调透明度、可重复性和多方证据的三角验证。主要资料来源包括与领域专家的结构化访谈、与平台开发人员和服务供应商的非正式讨论，以及揭示实际性能特征和整合考虑的技术演示。此外，还辅以同行评审文献、专利申请、监管指导文件和公司披露等二手信息，以检验技术声明并确定发展路径。

简明扼要地总结了各项结论，重点阐述了酶促DNA合成的战略转折点及其对科学和工业的长期影响。

这个结论简洁地概括了分析结果的战略意义，重点阐述了酶促DNA合成将在科学和工业领域产生最直接和最持久影响的领域。关键转折点包括酶工程和平台整合的成熟、自动化、数位化控制和品管系统的协调一致，以及目前阻碍其广泛商业化的供应链和监管挑战的解决。这些因素将共同决定酶促合成能否从高潜力示范阶段过渡到在研究、诊断和治疗药物生产中的常规应用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合新型聚合酵素工程技术以提高合成准确性和通量
  • 开发用于可扩展DNA组装的自动化微流体控酶平台
  • 透过引入专有的酵素化学技术，最大限度地减少核苷酸结合错误。
  • 扩大高通量酶促DNA合成规模，用于个人化细胞治疗分子
  • 生物製药公司与酵素技术Start-Ups公司之间的策略合作
  • 引入即时品管检测方法，以确保大规模合成的准确性
  • 影响酶促DNA产品商业化的法规结构的演变

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 酵素DNA合成市场：依产品/服务分类

  • 产品
    • 耗材和套件
    • DNA合成机器与平台
    • 酵素和试剂
  • 服务
    • 客製化DNA和寡核苷酸合成
    • 基因/DNA文库合成
    • 诱变和克隆服务
    • 次世代定序(NGS) 和 DNA 分析服务

第九章 酶促DNA合成市场：依技术划分

  • 模板依赖类型
    • 基于连接酶的合成
    • 基于聚合酵素的合成
  • 与模板无关
    • 设计的酶
    • 末端脱氧核苷酸转移酶

第十章 酵素DNA合成市场：依应用划分

  • 农业和工业用途
  • 医疗和诊断应用
  • 药物研发

第十一章 依最终用户分類的酵素DNA合成市场

  • 学术和研究机构
  • 合约研究组织（CRO）
  • 製药和生物技术公司

第十二章 各地区的酵素DNA合成市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按组别分類的酵素DNA合成市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国酵素DNA合成市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Aldevron LLC by Danaher Corporation
    • Almac Group Limited
    • Ansa Biotechnologies, Inc.
    • Biotium, Inc.
    • Biozym Scientific GmbH
    • Camena Bioscience
    • CD Genomics
    • DNA Script
    • Evonetix Ltd.
    • Merck KGaA
    • Molecular Assemblies by TriLink BioTechnologies LLC
    • Moligo Technologies AB
    • Stemnovate Limited
    • Telesis Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Touchlight Genetics Limited
    • Twist Bioscience Corporation
Product Code: MRR-1A1A064C059D

The Enzymatic DNA Synthesis Market is projected to grow by USD 1,213.77 million at a CAGR of 20.74% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 268.58 million
Estimated Year [2025] USD 319.56 million
Forecast Year [2032] USD 1,213.77 million
CAGR (%) 20.74%

A strategic overview introducing enzymatic DNA synthesis, its scientific foundations, industrial relevance, and why stakeholders must engage now

Enzymatic DNA synthesis represents a pivotal evolution in how nucleotide sequences are constructed, moving beyond traditional chemical phosphoramidite methods toward enzyme-mediated approaches that promise improvements in length, fidelity, and environmental footprint. This introduction situates the reader at the intersection of molecular biology, enzymology, and industrial process design, explaining the core biochemical mechanisms-template-dependent ligase and polymerase systems and template-independent terminal transferase strategies-while highlighting how enzyme engineering, process automation, and integrated quality control are converging to unlock new capabilities.

The section establishes context by outlining the drivers that make enzymatic approaches strategically relevant: reduced hazardous waste, potential for lower cost-per-base through enzymatic recycling and mild reaction conditions, and opportunities to scale synthesis beyond the constraints of stepwise chemical coupling. It also presents the practical implications for research workflows, diagnostics development, and therapeutic discovery, describing how improved synthesis fidelity and custom sequence capacity enable more complex libraries, longer constructs, and more reliable gene assemblies.

Finally, the introduction frames the remainder of the analysis by identifying the principal stakeholder groups affected by these shifts, including providers of enzymes and platforms, downstream service laboratories, and end users across academia, contract research organizations, and biotech and pharmaceutical companies. This perspective sets expectations for the report's analytical depth and the types of insights stakeholders will find most actionable.

How enzyme-driven platforms, automation, and computational design are shifting synthesis paradigms to enable sustainable, scalable, and precise DNA manufacture

The landscape of DNA synthesis is undergoing transformative shifts as enzyme-based methodologies progress from laboratory proofs of concept to deployable platforms. Historically, chemical synthesis dominated the field, but recent advances in enzyme engineering, improved process control, and integration with automation and bioinformatics have reframed the value equation. These developments reduce hazardous reagents and enable milder reaction conditions, which in turn lower process complexity and create pathways to longer and more accurate oligonucleotides and constructs.

Transitioning from bench to production requires not only robust enzymes but also sophisticated platform design and digital process controls. Integrated hardware and software ecosystems that manage reagent delivery, cycle optimization, and in-line analytical feedback are becoming differentiators. In parallel, computational design tools and error-correction chemistries are accelerating iteration cycles, allowing teams to move from design to validated sequence faster than before. Consequently, companies that can combine optimized enzymes with platform engineering and automated workflows gain substantial competitive advantage.

These shifts also reshape business models: platform vendors, reagent suppliers, and service providers are exploring hybrid offerings that bundle instruments with consumables and analytics services. The cumulative result is a more modular, scalable industry architecture where adaptability, interoperability, and rapid validation become critical success factors for stakeholders aiming to capitalize on enzymatic DNA synthesis.

An analytical review of how 2025 United States tariff measures are reshaping supply chains, procurement approaches, and global access to key synthesis inputs

United States tariff measures enacted in 2025 introduced a new layer of complexity to global supply chains supporting enzymatic DNA synthesis, with implications for procurement strategies, supplier selection, and cost structures. The immediate operational impact is observed in the sourcing timelines for critical inputs such as specialized enzymes, high-purity reagents, and capital equipment where cross-border logistics and customs duties can introduce variability and delay. As a result, procurement teams have re-evaluated supplier portfolios, prioritized inventory buffering for critical components, and accelerated qualification of alternative suppliers closer to final assembly locations.

In addition to operational responses, many organizations revised contractual terms to incorporate greater flexibility, including adjusted lead times, contingency clauses, and destination-based distribution models. Regulatory compliance and documentation have also become more prominent in supplier onboarding, as tariff classifications and origin rules require more granular traceability. Importantly, these policy changes have encouraged stronger collaboration among equipment vendors, reagent manufacturers, and service organizations to develop localized manufacturing options or regional assembly hubs that mitigate exposure to import duties.

Looking forward, the most resilient organizations will be those that combine diversified sourcing strategies with investments in supplier development, nearshoring critical components where feasible, and enhancing supply chain transparency. These measures will reduce operational disruption and help maintain steady access to the reagents, enzymes, and instruments essential for expanded deployment of enzymatic DNA synthesis.

Granular segmentation analysis across offering, technology, application, and end user that reveals drivers, constraints, and high-value opportunities

A nuanced understanding of market segmentation reveals how different dimensions of offering, technology, application, and end user drive distinct needs and investment priorities. By offering, the landscape divides into Products and Services, where Products encompass Consumables & Kits, DNA Synthesizers & Platforms, and Enzymes & Reagents, while Services include Custom DNA & Oligo Synthesis, Gene & DNA Library Synthesis, Mutagenesis & Cloning Services, and Next-Generation Sequencing and DNA Analysis Services. Each of these subsegments follows different innovation and revenue dynamics: consumables demand steady supply and quality consistency, platforms require capital and lifecycle support, and service offerings depend on throughput, quality assurance, and customer turnaround times.

From a technology perspective, the market separates along Template Dependent and Template Independent approaches. Template Dependent modalities include ligase-based and polymerase-based synthesis, which are often aligned with workflows requiring templated elongation and controlled sequence fidelity. Template Independent approaches, represented by engineered enzymes and terminal deoxynucleotidyl transferase strategies, offer flexibility for certain library constructions and non-templated extensions, often supporting novel assay formats and bespoke constructs.

Application-driven differences further stratify priorities into Agricultural & Industrial Uses, Medical & Diagnostic Applications, and Pharmaceutical & Drug Development. Each application segment imposes specific regulatory, scale, and validation requirements that influence technical roadmaps. Finally, end users such as Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies adopt distinct procurement and adoption timelines, with research institutions often piloting novel methods, CROs emphasizing reproducibility and throughput, and commercial firms prioritizing scalability and regulatory readiness. Understanding these layered segmentations enables more precise product development and commercialization strategies.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence investment decisions, collaboration models, and adoption

Regional dynamics play a decisive role in shaping how enzymatic DNA synthesis technologies are adopted, commercialized, and regulated across global markets. In the Americas, robust venture activity, established biotech clusters, and significant downstream demand for therapeutic development create fertile conditions for early platform adoption, while regulatory pathways and reimbursement environments encourage collaborations between instrument vendors and service laboratories. In contrast, Europe, Middle East & Africa present a mosaic of regulatory regimes, research funding patterns, and public-private partnership models that influence adoption cadence; here, emphasis often centers on compliance, cross-border collaborations, and sustainability standards.

Asia-Pacific combines rapidly growing capacity, significant public investment in life sciences, and strong manufacturing ecosystems that can accelerate scale-up and cost optimization. This region also demonstrates increasing capabilities in enzyme engineering and localized reagent production, reducing dependence on distant suppliers. Across all regions, differences in supply chain maturity, talent availability, and regulatory frameworks create heterogeneity in go-to-market strategies and partnership models. Consequently, firms seeking global reach should pursue region-specific strategies that account for local procurement practices, regulatory validation timelines, and the presence of clusters that can accelerate trials and early commercial deployments.

Ultimately, strategic investors and corporate leaders must align regional entry plans with local innovation ecosystems, leveraging partnerships and localized operations to mitigate trade-related risks and to capture the fastest-growing use cases.

Competitive profiles and partnership strategies of leading companies advancing enzymatic DNA synthesis innovation, platform rollout, and strategic collaborations

Key company insights emphasize the convergence of technological differentiation, strategic partnerships, and intellectual property as determinants of competitive positioning in enzymatic DNA synthesis. Leading organizations typically combine proprietary enzyme engineering, platform integration expertise, and recurring consumables models to create defensible revenue streams. In many cases, the most successful firms also pursue strategic collaborations with academic centers and contract laboratories to validate novel chemistries and to accelerate real-world use cases.

Partnership strategies are increasingly important; alliances with component suppliers, automation specialists, and analytical providers enable end-to-end solutions that reduce customer integration burden. Moreover, joint development agreements and licensing arrangements facilitate faster route-to-market for new enzyme variants or platform modules while spreading development risk. On the commercial side, companies are experimenting with hybrid revenue models that mix instrument sales, reagent subscriptions, and high-value services to align incentives across the value chain.

From an organizational perspective, companies that invest in rigorous quality systems, regulatory expertise, and scalable manufacturing processes are better positioned to transition from early adopters to broader market acceptance. Risk management practices, including diversified supply chains and contingency planning, further distinguish those able to maintain continuity of supply and service as enzymatic approaches become more widely adopted.

Actionable guidance for industry leaders to accelerate adoption, de-risk supply chains, and align R&D with commercial strategies for enzymatic DNA synthesis

Industry leaders seeking to capitalize on enzymatic DNA synthesis should adopt a combination of technological, operational, and commercial actions to accelerate value creation and reduce execution risk. First, prioritize investments in enzyme optimization and process analytics to improve fidelity and cycle efficiency; demonstrating reproducible performance in real-world workflows will drive customer trust and broader adoption. Concurrently, develop modular platform architectures and interoperable software that enable incremental upgrades, integration with laboratory information management systems, and smoother customer validation pathways.

Operationally, diversify supplier networks for critical reagents and consider regional manufacturing or assembly to mitigate tariff and logistics exposure. Strengthen supplier qualification processes and contractual terms to incorporate contingency planning. On the commercial front, expand pilot programs with strategic customers across academic, CRO, and pharmaceutical segments to gather application-specific validation data and to co-create service offerings that address distinct throughput and quality needs.

Finally, align corporate development with long-term goals by evaluating partnerships, licensing, and selective M&A that bring complementary capabilities in enzyme engineering, automation, or analytics. These combined actions will enable industry leaders to accelerate adoption, de-risk scale-up, and turn technological advances into sustainable commercial advantage.

A transparent research methodology detailing data sources, validation practices, expert interviews, and analytical approaches that yield rigorous insights

The research methodology underpinning this analysis emphasizes transparency, reproducibility, and triangulation across multiple evidence streams. Primary data sources included structured interviews with subject-matter experts, informal consultations with platform developers and service providers, and technology demonstrations that revealed practical performance characteristics and integration considerations. Secondary sources complemented these insights through peer-reviewed literature, patent filings, regulatory guidance documents, and company disclosures that together helped validate technical claims and identify developmental trajectories.

To ensure analytical rigor, data were cross-validated using multiple methods: qualitative interview inputs were compared with observed platform specifications, and claims about enzyme performance were assessed against independent validation studies where available. The approach also incorporated a thematic synthesis of regulatory and supply chain variables to contextualize technology adoption risks. Where uncertainties existed, sensitivity-driven scenario analysis and expert elicitation informed the interpretation of likely outcomes rather than quantitative forecasts.

Throughout, emphasis was placed on methodological clarity: assumptions are documented, evidence provenance is maintained, and limitations are explicitly acknowledged so that readers can interpret findings in light of specific organizational priorities and risk tolerances.

A concise synthesis of conclusions that underscore strategic inflection points and the long-term implications of enzymatic DNA synthesis for science and industry

The conclusion synthesizes the analysis into a concise set of strategic takeaways that highlight where enzymatic DNA synthesis will have the most immediate and durable impact across science and industry. Key inflection points include the maturation of enzyme engineering and platform integration; the alignment of automation and digital controls with quality systems; and the resolution of supply chain and regulatory hurdles that currently slow broader commercialization. Together, these factors determine whether enzyme-based synthesis moves from high-potential demonstrations to routine use in research, diagnostics, and therapeutic manufacturing.

For organizations already engaged with DNA synthesis workflows, the implication is clear: proactively evaluate enzymatic approaches through targeted pilots that emphasize analytical validation, cost-to-implement, and workflow interoperability. For investors and corporate strategists, the focus should be on companies demonstrating deep enzyme IP, scalable platform architectures, and defensible consumables models. Finally, for policymakers and infrastructure stakeholders, supporting local manufacturing capabilities, streamlined regulatory pathways, and collaborative validation frameworks will accelerate safe and equitable access to these technologies.

In sum, enzymatic DNA synthesis is poised to reshape key aspects of sequence construction and application. The pace and breadth of that change will depend on coordinated action across technology developers, end users, and supporting institutions to validate performance, ensure supply resilience, and align commercial models with real-world needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of novel polymerase engineering to enhance synthesis fidelity and throughput
  • 5.2. Development of automated microfluidic enzymatic platforms for scalable DNA assembly
  • 5.3. Adoption of proprietary enzymatic chemistries to minimize nucleotide coupling errors
  • 5.4. Expansion of high-throughput enzymatic DNA synthesis for personalized cell therapy molecules
  • 5.5. Strategic partnerships between biopharma companies and enzyme technology startups
  • 5.6. Implementation of real-time quality control assays to ensure synthesis accuracy at scale
  • 5.7. Regulatory framework developments impacting commercialization of enzymatic DNA products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enzymatic DNA Synthesis Market, by Offering

  • 8.1. Products
    • 8.1.1. Consumables & Kits
    • 8.1.2. DNA Synthesizers & Platforms
    • 8.1.3. Enzymes & Reagents
  • 8.2. Services
    • 8.2.1. Custom DNA & Oligo Synthesis
    • 8.2.2. Gene & DNA Library Synthesis
    • 8.2.3. Mutagenesis & Cloning Services
    • 8.2.4. Next-Generation Sequencing (NGS) & DNA Analysis Services

9. Enzymatic DNA Synthesis Market, by Technology

  • 9.1. Template Dependent
    • 9.1.1. Ligase Based Synthesis
    • 9.1.2. Polymerase Based Synthesis
  • 9.2. Template Independent
    • 9.2.1. Engineered Enzymes
    • 9.2.2. Terminal Deoxynucleotidyl Transferase

10. Enzymatic DNA Synthesis Market, by Application

  • 10.1. Agricultural & Industrial Uses
  • 10.2. Medical & Diagnostic Applications
  • 10.3. Pharmaceutical & Drug Development

11. Enzymatic DNA Synthesis Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations (CROs)
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Enzymatic DNA Synthesis Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enzymatic DNA Synthesis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enzymatic DNA Synthesis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Aldevron LLC by Danaher Corporation
    • 15.3.2. Almac Group Limited
    • 15.3.3. Ansa Biotechnologies, Inc.
    • 15.3.4. Biotium, Inc.
    • 15.3.5. Biozym Scientific GmbH
    • 15.3.6. Camena Bioscience
    • 15.3.7. CD Genomics
    • 15.3.8. DNA Script
    • 15.3.9. Evonetix Ltd.
    • 15.3.10. Merck KGaA
    • 15.3.11. Molecular Assemblies by TriLink BioTechnologies LLC
    • 15.3.12. Moligo Technologies AB
    • 15.3.13. Stemnovate Limited
    • 15.3.14. Telesis Bio Inc.
    • 15.3.15. Thermo Fisher Scientific Inc.
    • 15.3.16. Touchlight Genetics Limited
    • 15.3.17. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENZYMATIC DNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY